News from Charlotte McIntyre, MRCS, Clinical Research Fellow to Prof Neil Tolley, Otolaryngology - Head and Neck Surgery, Imperial College Healthcare NHS Trust, London and Jonathan Bernstein, MD, FRCS, Consultant in Head and Neck and Thyroid Surgical OncologyThyroid Unit, The Royal Marsden NHS Foundation Trust , London, UK
The 3rd World Congress on Thyroid Cancer was held in Boston in July 2017. This international meeting on thyroid cancer and thyroid nodular disease builds on the success of the first two world congresses which were both held in Toronto in 2009 and 2013 under Dr Jeremy Freeman.
The congress has now grown to more than 1400 delegates who attended this year in Boston. The meeting fostered a multidisciplinary approach to the discussion of management of and research in thyroid cancer, with delegates attending from a broad range of backgrounds: otolaryngology - head and neck surgeons, general surgeons, radiation oncologists, medical oncologists, endocrinologists, nuclear medicine physicians, pathologists, radiologists and the allied healthcare professionals.
The meeting was attended by delegates from more than 70 different countries around the world, making this conference an international celebration of worldwide expertise.
The congress was delivered in an interesting variety of different formats with a number of keynote lectures, hot topic lectures, panel discussions, video sessions, ‘meet the professors’, instructional courses, oral paper sessions and an e-poster exhibition. All aspects of thyroid cancer were covered from the investigation of thyroid nodules to the management of surgical complications, long-term surveillance and tumour recurrence. There was an emphasis on the genetic landscape of thyroid cancer and the emerging evidence for the use of molecular markers and genetic array testing in the investigation of thyroid nodules.
Highlighted throughout the meeting was the change in international guidelines since the previous meeting in 2013. There has been a general trend towards less surgery and adjuvant radioiodine in well-differentiated thyroid cancer. Notable sessions included the lecture ‘One size does not fit all: selecting tumours for active surveillance or less aggressive surgery’, a lecture on the management of non-invasive follicular thyroid neoplasms (NIFTP), the panel on the comparison of international guidelines, and the panel on complex invasive thyroid malignancies. There was a fascinating keynote on the ‘Legacy of Theodor Kocher’ who won the Nobel Prize in 1909 for his work on thyroid surgery.
The ‘meet the professors’ sessions were an excellent opportunity to hear the first-hand experience of world renowned experts and understand their clinical decision making covering topics including reoperative central compartment dissection, minimally invasive surgery and tips and techniques to avoid complications in thyroid surgery. The operative video sessions were also a highlight.
Overall, the congress was a huge success providing not only a fantastic educational experience but also the opportunity to develop international relationships with other thyroid cancer centres around the world. There was a strong contingent of British clinicians. It was an inspiration to see the research and work that is taking place not only in the UK but around the world towards improving the management and care for patients with thyroid cancer.
Tom Milner, Richard Egan, Lottie Mcintyre, Prof Neil Tolley, David Scott-Coombes and Ian Hay at Boston Waterfront
“The World Congress on Thyroid Cancer 3.5 will be held in Rome in 2019 as well as The World Congress on Thyroid Cancer 4.0 in Boston in 2021! We look forward to seeing you there!” Gregory W. Randolph MD FACS FACE, Professor of Otolaryngology Head and Neck Surgery, Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology, Harvard Medical School, Director General and Thyroid/Parathyroid Endocrine Surgical Divisions, Immediate Past President American Academy of Otolaryngology Head and Neck Surgery. ENT & Audiology News ILC member.